4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl-

4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- manufacturers

4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Basic information
Product Name:4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl-
Synonyms:4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl-;DPP-4/GPR119 modulator 2
CAS:2010927-65-6
MF:C30H40N8O3
MW:560.69
EINECS:
Product Categories:
Mol File:2010927-65-6.mol
4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Structure
4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Chemical Properties
density 1.32±0.1 g/cm3(Predicted)
pka14.58±0.70(Predicted)
Safety Information
MSDS Information
4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Usage And Synthesis
UsesDPP-4/GPR119 modulator 2 (Compound 20i) is a dipeptidyl peptidase IV (DPP-IV) inhibitor and GPR119 agonist with an IC50 of 0.22 μM for DPP-IV and an EC50 of 0.95 μM for GPR119. DPP-4/GPR119 modulator 2 can be used for diabetes research[1]. DPP-4/GPR119 modulator 2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
IC 50DPP-4
References[1] Li G, et al. The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119. Eur J Med Chem. 2020 Feb 15;188:112017. DOI:10.1016/j.ejmech.2019.112017
4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Preparation Products And Raw materials
Tag:4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl-(2010927-65-6) Related Product Information
8-(3,5-dimethylpiperidin-1-yl)-3-methyl-7-pentylpurine-2,6-dione 4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- 7-hexyl-3-methyl-8-(3-methylpiperidin-1-yl)purine-2,6-dione Linagliptin Impurity 3 NA 1-(7-allyl-1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidine-4-carboxamide